-
Faecal Microbiota Transplant for Parkinson’s Disease: a Phase 1 Pilot Study to Establish Safety and Tolerability
-
Fahr’s Disease Presenting as Chorea: A Rare Case Report
-
Familial Multiple System Atrophy-Mimics: Importance of Comprehensive Evaluation
-
Fatigue in Parkinson’s Disease: Prevalence and Risk Factors
-
Fatigue in PD is related to decreased efficiency of the frontal network
-
Feasibility and added value of sensing feature in patients with chronic STN DBS for Parkinson’s disease
-
Feasibility and Comprehensibility of the SMD Decision Tree for Early Recognition of Spasticity
-
Feasibility and Preliminary Efficacy of a Pilot Telehealth Physical Activity Intervention in Degenerative Cerebellar Disease (Engage-Ataxia)
-
Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort
-
Feasibility of Reliable, Remote Assessment of a 13-year-old Boy Who Stopped Talking
-
FGF14 repeat expansions: prevalence and case series of patients with SCA27B from Slovakia
-
First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease
-
First-In-Human Single and Multiple Ascending Dose Trial Design of LY3962681, a Novel Intrathecally Delivered siRNA Targeting α-synuclein mRNA for the Treatment of Patients with Parkinson’s Disease
-
Five-Year Changes in MDS-UPDRS-III after Light Treatment (Photobiomodulation)
-
Fixel Analysis of Diffusion Imaging in Cerebellar Tracts as a Quantitative Marker of Disease Progression in Spinocerebellar Ataxia
-
Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO), A Novel Retinal Mitochondrial Biomarker For Parkinson’s Disease
-
Focused ultrasound subthalamotomy in early Parkinson´s disease: three-year prospective follow-up
-
Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome
-
Focused Ultrasound Therapy Treatment for Parkinson’s Disease
-
Formulations and Assessments of Intra-nasal noses to brain curcumin delivery using reversible nanoparticles for Parkinsonism treatment: A Preclinical Approach
-
Free-living digital mobility outcomes in Parkinson’s disease patients with and without freezing of gait: what can they tell us?
-
Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease
-
Free-water MRI Correlates of Pareidolia in Dementia with Lewy Bodies
-
Frequency of Falls as a Presenti̇ng Symptom and Its Effect i̇n Prognosi̇s i̇n Progressi̇ve Supranuclear Palsy
-
Frequency of LRRK2 p.L1795F variant in Parkinson’s Disease patients from Central Europe within the CEGEMOD consortium
-
Frequency of Variants of Uncertain Significance in a Cohort of Early-onset Parkinson’s Disease Patients
-
Friedreich’s ataxia: A descriptive study of a Tunisian cohort
-
From Images to Insights: Subtyping Parkinson’s Disease Using Unsupervised Learning on MRI Data
-
Frontal atrophy in progressive supranuclear palsy[PSP] -an universal feature along with midbrain atrophy?
-
Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease
-
Frontal Lobe Cortical Thickness and Volumetric Analysis in Parkinson’s Disease Based on Impulse Control Disorder
-
Functional Changes Occuring During 10-Week Parkinson’s Disease Group Fitness Classes and Subsequent 8-Week Break
-
Functional Connectivity Changes Associated with Interlimb Coordination Force Deficits in Parkinson’s Disease
-
Functional connectivity enhances prediction of STN DBS motor outcomes
-
Functional Motor Disorders in pediatrics: motor patterns and clinical correlates.
-
Functional neurological disorders might be a frequent cause of slow orthostatic tremor: insights from a case series.
-
Functionality Analysis of Immunoregulatory Cells Stimulated with Dopaminergic Agonists in People Living with Parkinson’s Disease
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.